John McFarland Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John McFarland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John McFarland. John McFarland is SVP, General Counsel & Sec. in SYNAPTICS Inc ($SYNA) and Executive VP, GC & Secretary in MAGNACHIP SEMICONDUCTOR Corp ($MX) and See Remarks in MAGNACHIP SEMICONDUCTOR Corp ($MX).
Latest Insider Trading Transactions of John McFarland
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.77 | 3,575 | 195,803 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 54.36 | 3,575 | 194,337 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 52.57 | 3,575 | 187,938 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 51.95 | 2,725 | 141,564 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 71.55 | 2,725 | 194,974 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 73.31 | 2,725 | 199,770 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 85.69 | 3,000 | 257,070 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 76.81 | 3,000 | 230,430 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 89.29 | 2,725 | 243,315 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 79.38 | 3,000 | 238,140 | 0 | |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 123.02 | 7,722 | 949,934 | 14,860 | 22.6 K to 14.9 K (-34.20 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 122.59 | 4,328 | 530,574 | 22,582 | 26.9 K to 22.6 K (-16.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.41 | 1,400 | 169,971 | 26,910 | 28.3 K to 26.9 K (-4.95 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.77 | 3,575 | 195,803 | 28,310 | 24.7 K to 28.3 K (+14.45 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 54.36 | 3,575 | 194,337 | 24,735 | 21.2 K to 24.7 K (+16.90 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 52.57 | 3,575 | 187,938 | 21,160 | 17.6 K to 21.2 K (+20.33 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 51.95 | 2,725 | 141,564 | 17,585 | 14.9 K to 17.6 K (+18.34 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 121.47 | 4,211 | 511,496 | 14,860 | 19.1 K to 14.9 K (-22.08 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 120.43 | 1,674 | 201,606 | 19,071 | 20.7 K to 19.1 K (-8.07 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 118.66 | 8,190 | 971,826 | 20,745 | 28.9 K to 20.7 K (-28.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 117.47 | 3,100 | 364,154 | 28,935 | 32 K to 28.9 K (-9.68 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 71.55 | 2,725 | 194,974 | 32,035 | 29.3 K to 32 K (+9.30 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 73.31 | 2,725 | 199,770 | 29,310 | 26.6 K to 29.3 K (+10.25 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 85.69 | 3,000 | 257,070 | 26,585 | 23.6 K to 26.6 K (+12.72 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 76.81 | 3,000 | 230,430 | 23,585 | 20.6 K to 23.6 K (+14.57 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 89.29 | 2,725 | 243,315 | 20,585 | 17.9 K to 20.6 K (+15.26 %) |
Feb 10 2021 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 79.38 | 3,000 | 238,140 | 17,860 | 14.9 K to 17.9 K (+20.19 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 84.50 | 300 | 25,349 | 14,860 | 15.2 K to 14.9 K (-1.98 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 83.38 | 4,383 | 365,473 | 15,160 | 19.5 K to 15.2 K (-22.43 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 82.41 | 2,097 | 172,805 | 19,543 | 21.6 K to 19.5 K (-9.69 %) |
Nov 10 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 81.60 | 3,695 | 301,511 | 21,640 | 25.3 K to 21.6 K (-14.58 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 76.67 | 5,236 | 401,444 | 25,335 | 30.6 K to 25.3 K (-17.13 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 76.67 | 6,266 | 480,414 | 30,571 | 36.8 K to 30.6 K (-17.01 %) |
Nov 03 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 11,971 | 0 | 36,837 | 24.9 K to 36.8 K (+48.14 %) |
Oct 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 83.41 | 1,403 | 117,023 | 24,866 | 26.3 K to 24.9 K (-5.34 %) |
Oct 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 82.92 | 7,811 | 647,718 | 26,269 | 34.1 K to 26.3 K (-22.92 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 81.66 | 10,121 | 826,481 | 34,080 | 44.2 K to 34.1 K (-22.90 %) |
Oct 09 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 19,335 | 0 | 44,201 | 24.9 K to 44.2 K (+77.76 %) |
Aug 19 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 6,946 | 0 | 24,826 | 17.9 K to 24.8 K (+38.85 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 45.32 | 298 | 13,505 | 0 | |
Aug 12 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 88.99 | 298 | 26,519 | 17,880 | 18.2 K to 17.9 K (-1.64 %) |
Aug 12 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 45.32 | 298 | 13,505 | 18,178 | 17.9 K to 18.2 K (+1.67 %) |
Jul 23 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 62.11 | 3,000 | 186,315 | 0 | |
Jul 23 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 80.00 | 3,000 | 240,000 | 17,880 | 20.9 K to 17.9 K (-14.37 %) |
Jul 23 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 62.11 | 3,000 | 186,315 | 20,880 | 17.9 K to 20.9 K (+16.78 %) |
Jun 08 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 59.34 | 5,000 | 296,700 | 0 | |
Jun 08 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 70.01 | 4,000 | 280,040 | 17,880 | 21.9 K to 17.9 K (-18.28 %) |
Jun 08 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 70.00 | 1,000 | 70,000 | 21,880 | 22.9 K to 21.9 K (-4.37 %) |
Jun 08 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 59.34 | 5,000 | 296,700 | 22,880 | 17.9 K to 22.9 K (+27.96 %) |
May 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 45.32 | 3,277 | 148,514 | 298 | |
May 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 67.14 | 61 | 4,096 | 17,880 | 17.9 K to 17.9 K (-0.34 %) |
May 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 66.29 | 2,343 | 155,324 | 17,941 | 20.3 K to 17.9 K (-11.55 %) |
May 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 65.59 | 4,251 | 278,828 | 20,284 | 24.5 K to 20.3 K (-17.33 %) |
May 13 2020 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 45.32 | 3,277 | 148,514 | 24,535 | 21.3 K to 24.5 K (+15.42 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 279 | 12,856 | 0 | |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 279 | 12,856 | 0 | |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 57.83 | 6,988 | 404,116 | 21,173 | 28.2 K to 21.2 K (-24.81 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 57.83 | 6,988 | 404,116 | 21,173 | 28.2 K to 21.2 K (-24.81 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 58.00 | 279 | 16,182 | 28,161 | 28.4 K to 28.2 K (-0.98 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 58.00 | 279 | 16,182 | 28,161 | 28.4 K to 28.2 K (-0.98 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 279 | 12,856 | 28,440 | 28.2 K to 28.4 K (+0.99 %) |
Nov 13 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 279 | 12,856 | 28,440 | 28.2 K to 28.4 K (+0.99 %) |
Nov 05 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 11,042 | 0 | 28,161 | 17.1 K to 28.2 K (+64.50 %) |
Nov 05 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 42.11 | 4,305 | 181,284 | 17,119 | 21.4 K to 17.1 K (-20.09 %) |
Nov 05 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 42.11 | 3,455 | 145,490 | 21,424 | 24.9 K to 21.4 K (-13.89 %) |
Nov 05 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 6,604 | 0 | 24,879 | 18.3 K to 24.9 K (+36.14 %) |
Oct 08 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 41.00 | 2,926 | 119,966 | 18,275 | 21.2 K to 18.3 K (-13.80 %) |
May 15 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 33.76 | 788 | 26,603 | 21,083 | 21.9 K to 21.1 K (-3.60 %) |
May 15 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 33.76 | 2,041 | 68,904 | 21,871 | 23.9 K to 21.9 K (-8.54 %) |
Feb 04 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 39.80 | 1,133 | 45,093 | 23,912 | 25 K to 23.9 K (-4.52 %) |
Feb 04 2019 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 3,174 | 0 | 25,045 | 21.9 K to 25 K (+14.51 %) |
Nov 15 2018 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 9,566 | 0 | 21,871 | 12.3 K to 21.9 K (+77.74 %) |
Nov 02 2018 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 37.54 | 3,286 | 123,356 | 12,305 | 15.6 K to 12.3 K (-21.08 %) |
Jun 22 2018 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 55.00 | 2,853 | 156,915 | 15,591 | 18.4 K to 15.6 K (-15.47 %) |
Feb 15 2018 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 45.00 | 641 | 28,845 | 18,391 | 19 K to 18.4 K (-3.37 %) |
Nov 02 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 9,411 | 0 | 18,982 | 9.6 K to 19 K (+98.33 %) |
Nov 02 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 37.12 | 1,214 | 45,064 | 9,571 | 10.8 K to 9.6 K (-11.26 %) |
Aug 07 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 45.32 | 3,575 | 162,019 | 3,575 | |
May 02 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 54.77 | 3,575 | 195,803 | 3,575 | |
May 02 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 53.65 | 76 | 4,077 | 10,753 | 10.8 K to 10.8 K (-0.70 %) |
Feb 02 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 56.38 | 91 | 5,131 | 10,829 | 10.9 K to 10.8 K (-0.83 %) |
Jan 30 2017 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 54.36 | 3,575 | 194,337 | 3,575 | |
Nov 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 52.57 | 3,575 | 187,938 | 3,575 | |
Nov 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 52.12 | 735 | 38,308 | 10,887 | 11.6 K to 10.9 K (-6.32 %) |
Nov 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 5,700 | 0 | 11,622 | 5.9 K to 11.6 K (+96.25 %) |
Oct 07 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 278 | 12,810 | 279 | |
Oct 07 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 65.00 | 1,526 | 99,190 | 5,922 | 7.4 K to 5.9 K (-20.49 %) |
Oct 07 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 60.00 | 278 | 16,680 | 7,448 | 7.7 K to 7.4 K (-3.60 %) |
Oct 07 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 278 | 12,810 | 7,726 | 7.4 K to 7.7 K (+3.73 %) |
Sep 12 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 277 | 12,764 | 557 | |
Sep 12 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 60.00 | 277 | 16,620 | 7,448 | 7.7 K to 7.4 K (-3.59 %) |
Sep 12 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 277 | 12,764 | 7,725 | 7.4 K to 7.7 K (+3.72 %) |
Sep 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 2,778 | 128,010 | 834 | |
Sep 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 60.00 | 2,778 | 166,680 | 7,448 | 10.2 K to 7.4 K (-27.17 %) |
Sep 01 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 2,778 | 128,010 | 10,226 | 7.4 K to 10.2 K (+37.30 %) |
Aug 02 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 51.95 | 2,725 | 141,564 | 2,725 | |
Aug 02 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 57.20 | 234 | 13,385 | 7,448 | 7.7 K to 7.4 K (-3.05 %) |
May 03 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 71.55 | 2,725 | 194,974 | 2,725 | |
May 03 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 69.09 | 234 | 16,166 | 7,650 | 7.9 K to 7.7 K (-2.97 %) |
Feb 02 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 73.31 | 2,725 | 199,770 | 2,725 | |
Feb 02 2016 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 73.68 | 273 | 20,115 | 7,884 | 8.2 K to 7.9 K (-3.35 %) |
Nov 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 86.69 | 234 | 20,285 | 8,126 | 8.4 K to 8.1 K (-2.80 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 834 | 38,431 | 3,612 | |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 89.29 | 2,725 | 243,315 | 2,725 | |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 86.64 | 300 | 25,991 | 8,360 | 8.7 K to 8.4 K (-3.46 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 85.52 | 534 | 45,670 | 8,660 | 9.2 K to 8.7 K (-5.81 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 834 | 38,431 | 9,194 | 8.4 K to 9.2 K (+9.98 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 89.29 | 473 | 42,234 | 8,360 | 8.8 K to 8.4 K (-5.35 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 1,261 | 0 | 8,833 | 7.6 K to 8.8 K (+16.65 %) |
Oct 27 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Grant | A | 0.00 | 4,000 | 0 | 7,572 | 3.6 K to 7.6 K (+111.98 %) |
Aug 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 833 | 38,385 | 4,446 | |
Aug 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 79.38 | 3,000 | 238,140 | 3,000 | |
Aug 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 78.75 | 1,614 | 127,103 | 3,572 | 5.2 K to 3.6 K (-31.12 %) |
Aug 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 833 | 38,385 | 5,186 | 4.4 K to 5.2 K (+19.14 %) |
Aug 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 79.38 | 234 | 18,575 | 4,353 | 4.6 K to 4.4 K (-5.10 %) |
May 04 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Payment of Exercise | F | 84.72 | 234 | 19,824 | 4,558 | 4.8 K to 4.6 K (-4.88 %) |
Apr 28 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | M | 46.08 | 841 | 38,753 | 5,279 | |
Apr 28 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Option Exercise | A | 85.69 | 3,000 | 257,070 | 3,000 | |
Apr 28 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Sell | S | 85.18 | 1,232 | 104,939 | 4,792 | 6 K to 4.8 K (-20.45 %) |
Apr 28 2015 | SYNA | SYNAPTICS Inc | McFarland John | SVP, General Counse ... | Buy | M | 46.08 | 841 | 38,753 | 6,024 | 5.2 K to 6 K (+16.23 %) |
Aug 23 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Option Exercise | M | 5.88 | 16,021 | 94,203 | 11,979 | |
Aug 23 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Sell | S | 20.00 | 6,860 | 137,200 | 13,860 | 20.7 K to 13.9 K (-33.11 %) |
Aug 23 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Sell | S | 20.00 | 119 | 2,380 | 20,720 | 20.8 K to 20.7 K (-0.57 %) |
Aug 23 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Sell | S | 20.00 | 16,021 | 320,420 | 20,839 | 36.9 K to 20.8 K (-43.46 %) |
Aug 23 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Buy | M | 5.88 | 16,021 | 94,203 | 36,860 | 20.8 K to 36.9 K (+76.88 %) |
Mar 18 2013 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Sell | S | 17.00 | 7,000 | 119,000 | 20,839 | 27.8 K to 20.8 K (-25.14 %) |
Dec 04 2012 | MX | MAGNACHIP SEMICOND ... | McFarland John | Executive VP, GC & ... | Sell | S | 12.67 | 14,280 | 180,928 | 27,839 | 42.1 K to 27.8 K (-33.90 %) |
Feb 02 2012 | MX | MAGNACHIP SEMICOND ... | McFarland John | See Remarks | Option Exercise | A | 7.75 | 30,000 | 232,500 | 30,000 |
Page: 1